COVID-19 is characterized by the activation of a subset of cTfh cells with reduced CCR7 expression, high expression of PD-1 and high expression of ICOS-1 expression, which remains active for up to two weeks after symptoms occur (Gong et al., 2020). The gene discussed is CCR7; the disease is COVID-19.